MCM
M28 Capital Management Portfolio holdings
AUM
$58.6M
This Quarter Return
-5.79%
1 Year Return
+32.71%
3 Year Return
+247.5%
5 Year Return
–
10 Year Return
–
AUM
$58.6M
AUM Growth
+$58.6M
(-20%)
Cap. Flow
-$6.63M
Cap. Flow
% of AUM
-11.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$4.19M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$2.44M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Wave Life Sciences
WVE
$1.53B
| $36.8M | 62.8% | 5,664,548 | – | – |
|
2
Invivyd
IVVD
$204M
| $6.61M | 11.28% | 9,248,250 | – | – |
|
3
TG Therapeutics
TGTX
$4.65B
| $5.82M | 9.92% | 161,600 | – | – |
|
4
Fractyl Health
GUTS
$68.8M
| $3.01M | 5.13% | 1,856,117 | – | – |
|
5
ProQR Therapeutics
PRQR
$237M
| $2.08M | 3.55% | 1,019,498 | – | – |
|
6
Curis
CRIS
$20.9M
| $1.21M | 2.06% | 521,059 | – | – |
|
|
SLN
7
Silence Therapeutics
SLN
$227M
| $1.07M | 1.83% | 185,100 | – | – |
|
8
Arrowhead Research
ARWR
$3.05B
| $1.06M | 1.82% | 67,400 | – | – |
|
9
Rocket Pharmaceuticals
RCKT
$354M
| $945K | 1.61% | 385,680 | – | – |
|
|
10
BridgeBio Pharma
BBIO
$9.89B
| – | – | -121,200 | Closed | -$4.19M |
|
|
SWTX
11
DELISTED
SpringWorks Therapeutics
SWTX
| – | – | -55,200 | Closed | -$2.44M |
|